We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Lilly

News List

Pfizer & Lilly's non-opioid drug reduces pain in osteoarthritis pharmafile
October 25, 2018
Pfizer and Eli Lilly have announced data revealing that their nerve growth factor (NGF) inhibitor tanezumab met all three of its co-primary endpoints in the treatment of osteoarthritis (OA).
Skovronsky to take over Lilly Research Labs as Lundberg retires fiercebiotech
September 30, 2017
After eight years at Eli Lilly and heading up its Lilly Research Labs unit, Jan Lundberg, Ph.D., will retire next May as Dan Skovronsky, M.D., Ph.D., will be promoted to replace him.
Pfizer and Lilly receive FDA Fast Track designation for tanezumab worldpharmanews
June 14, 2017
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for tanezumab for the treatment of chronic pain in patients with osteoarthritis (OA) and chroni